The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1049
March 26, 1999
View Complete Issue         Table of Contents 2019 
Lyme Disease Vaccine
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Lyme Disease Vaccine
March 26, 1999 (Issue: 1049)
The first human vaccine for prevention of Lyme disease (LYMErix), has been approved by the FDA for use in patients 15 to 70 years old.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Lyme Disease Vaccine
Article code: 1049a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.